Cas no 635712-44-6 (5-Bromo-7-chloro-1H-indazole)
5-Bromo-7-chloro-1H-indazole Chemical and Physical Properties
Names and Identifiers
-
- 5-Bromo-7-chloro-1H-indazole
- 1H-Indazole, 5-bromo-7-chloro-
- 1H-Indazole,5-bromo-7-chloro
- 5-BROMO-7-CHLOROINDAZOLE
- PubChem20591
- 1H-Indazole,5-bromo-7-chloro-
- IQSRPQLSDHXAIZ-UHFFFAOYSA-N
- BCP27204
- INDAZOLE, 5-BROMO-7-CHLORO-
- MB09125
- FCH1401857
- RP08941
- BC004575
- BC257481
- ST1100648
- AX8103013
- AB0031017
- X3335
- A8752
- 4
- AC-28249
- FT-0649442
- AMY24482
- CS-0041815
- SCHEMBL3601695
- SY025378
- Z1269130417
- DS-12811
- EN300-3215626
- J-517141
- DTXSID70610771
- MFCD11044588
- AKOS005258442
- 635712-44-6
-
- MDL: MFCD11044588
- Inchi: 1S/C7H4BrClN2/c8-5-1-4-3-10-11-7(4)6(9)2-5/h1-3H,(H,10,11)
- InChI Key: IQSRPQLSDHXAIZ-UHFFFAOYSA-N
- SMILES: BrC1C=C(C2=C(C=NN2)C=1)Cl
Computed Properties
- Exact Mass: 229.92500
- Monoisotopic Mass: 229.925
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 155
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.3
- Topological Polar Surface Area: 28.7
Experimental Properties
- Density: 1.878
- Melting Point: ca 205℃
- Boiling Point: 364.1°C at 760 mmHg
- Flash Point: 364.1 °C at 760 mmHg
- Refractive Index: 1.73
- PSA: 28.68000
- LogP: 2.97880
5-Bromo-7-chloro-1H-indazole Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Storage Condition:Sealed in dry,Room Temperature
5-Bromo-7-chloro-1H-indazole Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Bromo-7-chloro-1H-indazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | GJ096-250mg |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 97% | 250mg |
736CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | GJ096-1g |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 97% | 1g |
1842CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | GJ096-10g |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 97% | 10g |
9510CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | GJ096-100mg |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 97% | 100mg |
491CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | GJ096-5g |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 97% | 5g |
5696CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0397-1g |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 96% | 1g |
1272.06CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0397-5g |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 96% | 5g |
3816.19CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0397-25g |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 96% | 25g |
12720.64CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0397-500mg |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 96% | 500mg |
1060.05CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0397-250mg |
5-Bromo-7-chloro-1H-indazole |
635712-44-6 | 96% | 250mg |
924.37CNY | 2021-05-08 |
5-Bromo-7-chloro-1H-indazole Related Literature
-
Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
Additional information on 5-Bromo-7-chloro-1H-indazole
5-Bromo-7-chloro-1H-indazole (CAS No. 635712-44-6): A Comprehensive Overview
5-Bromo-7-chloro-1H-indazole (CAS No. 635712-44-6) is a heterocyclic organic compound belonging to the indazole family. This compound has gained significant attention in pharmaceutical and materials science research due to its unique structural features and potential applications. The presence of both bromo and chloro substituents on the indazole ring makes it a valuable intermediate for further chemical modifications.
The molecular formula of 5-Bromo-7-chloro-1H-indazole is C7H4BrClN2, with a molecular weight of 231.48 g/mol. Its structure consists of a fused benzene and pyrazole ring system, with bromine and chlorine atoms at the 5 and 7 positions, respectively. This specific substitution pattern contributes to the compound's electronic properties and reactivity, making it particularly interesting for medicinal chemistry applications.
Recent studies have highlighted the importance of halogenated indazole derivatives in drug discovery. The 5-Bromo-7-chloro-1H-indazole scaffold serves as a key building block for the synthesis of various biologically active compounds. Researchers are particularly interested in its potential applications in developing kinase inhibitors, which are crucial for treating various diseases. The compound's ability to participate in diverse chemical reactions makes it a versatile intermediate in organic synthesis.
From a synthetic chemistry perspective, 5-Bromo-7-chloro-1H-indazole offers several advantages. The presence of both halogen atoms allows for selective functionalization through cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These transformations enable the creation of more complex molecular architectures that are valuable in pharmaceutical research. The compound's stability under various reaction conditions further enhances its utility as a synthetic intermediate.
The pharmaceutical industry has shown growing interest in indazole-based compounds due to their diverse biological activities. 5-Bromo-7-chloro-1H-indazole serves as a precursor for molecules with potential therapeutic applications in areas such as oncology, neurology, and inflammation. Researchers are actively investigating its derivatives as potential drug candidates, particularly focusing on their interactions with various biological targets.
In materials science, halogenated indazoles like 5-Bromo-7-chloro-1H-indazole have found applications in the development of organic electronic materials. The electron-withdrawing nature of the halogen substituents influences the compound's electronic properties, making it suitable for use in organic semiconductors or as a component in light-emitting materials. These applications align with current trends in sustainable and organic electronics.
The analytical characterization of 5-Bromo-7-chloro-1H-indazole typically involves techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods ensure the compound's purity and confirm its structural identity, which is crucial for research and industrial applications. The compound generally appears as a white to off-white crystalline powder with good stability under standard storage conditions.
Market trends indicate increasing demand for specialized indazole derivatives like 5-Bromo-7-chloro-1H-indazole. Pharmaceutical and biotechnology companies are actively sourcing high-quality intermediates for their drug discovery programs. The compound's commercial availability from specialized chemical suppliers has made it more accessible to researchers worldwide, facilitating advancements in various scientific fields.
Safety considerations for handling 5-Bromo-7-chloro-1H-indazole follow standard laboratory practices for organic compounds. While not classified as hazardous under normal circumstances, proper personal protective equipment should be used when working with this chemical. Researchers should consult the material safety data sheet (MSDS) for specific handling and storage recommendations to ensure safe laboratory practices.
Future research directions for 5-Bromo-7-chloro-1H-indazole include exploring its potential in green chemistry applications and developing more efficient synthetic routes. The compound's versatility makes it a promising candidate for various innovative applications in medicinal chemistry and materials science. As research continues, we can expect to see new discoveries leveraging this interesting molecular scaffold.
For researchers interested in halogenated heterocycles or pharmaceutical intermediates, 5-Bromo-7-chloro-1H-indazole represents an important compound with diverse applications. Its unique structural features and reactivity profile continue to make it a valuable tool in modern chemical research and drug development efforts across multiple disciplines.
635712-44-6 (5-Bromo-7-chloro-1H-indazole) Related Products
- 1800426-14-5(7-Bromo-4-chlorocinnoline)
- 885518-99-0(6-Bromo-4-chloro-1H-indazole)
- 885519-03-9(4-Bromo-6-chloro-1H-indazole)
- 1305208-02-9(6-bromo-5-chloro-1H-indazole)
- 1186334-61-1(4-Bromo-7-chloro-1H-indazole)
- 50477-27-5(5,7-Dichloro-1H-indazole)
- 68211-15-4(6-Bromo-4-chlorocinnoline)
- 37435-12-4(7-Chloro-1H-indazole)
- 875305-86-5(7-Bromo-5-chloro-1H-indazole)
- 1260382-77-1(5-Bromo-6-chloro-1H-indazole)